Lombard Medical Technologies Plc
| London Stock Exchange: LMT
Lombard Medical Technologies Plc is a medical technology company, which specializes in research and development, design, manufacture and commercialization of endovascular solutions. The company's product, Aorfix endovascular stent graft, reduces endovascular aortic repair complications, such as proximal endoleaks, graft migration and iliac occlusion in patients with both standard and complex abdominal aortic aneurysm anatomies. Lombard Medical Technologies was founded in July 2000 and is headquartered in Didcot, the United Kingdom.